Full-Time

Gxp Data Integrity & Governance Manager

Confirmed live in the last 24 hours

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Biotechnology firm specializing in antibody therapies

Biotechnology
Healthcare

Compensation Overview

CA$96.9k - CA$121.2kAnnually

+ Equity + Annual Bonus + RRSP Contribution

Senior

Vancouver, BC, Canada

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • 5 years of industry experience in data management, data governance, or data integrity with a proven record of successfully implementing DI Governance programs (or equivalent)
  • a bachelor’s degree in a scientific, mathematics, statistics, engineering, or business discipline
  • a working knowledge of industry best practice including health authority regulation guidance and industry guidelines (PICs / ISPE GAMP etc.) for data integrity, data governance, and data management within a life science environment
  • subject matter expertise in ERES, DI, and risk management requirements for Health Canada, EU EMA, FDA, MHRA regulatory environments (this would be a strong asset)
  • technical familiarity with data architecture principles and design aspects of various data and analytics solutions
  • outstanding communicator, team player, and relationship builder
  • inspired by working with teammates and partners to bring innovative medicines to patients, and known for attention to detail, timelines and creative thinking
  • Lean Six Sigma training and/or accreditation (this would be a strong asset)
Responsibilities
  • Providing hands-on development, execution and coordination of activities related to our data integrity (DI) governance program including developing DI plans, process mapping, performing gap assessment or remediation planning, and performing control processes
  • Facilitating the Data Integrity Community of Practice and serving as the DI Subject Matter Expert (SME)
  • Working with the data governance function to ensure accountability for the stewardship and appropriate control of data assets supporting Health Authority Regulated (HAR) activities
  • Promoting cross-functional collaboration to develop a "DI by design" mindset and achieve sustainable DI compliance
  • Providing the quality management team with information on the performance of the data integrity governance program
  • Defining roles and responsibilities for data integrity & governance supporting data management and usage in a HAR / GxP environment
  • Creating and delivering cross-functional DI training and managing knowledge sharing. Additionally, develop and utilize metrics and KPIs to ensure the success of DI programs
  • Offering support during regulatory agency and third-party inspections

AbCellera specializes in discovering and developing therapeutic antibodies for various diseases. The company uses a proprietary technology platform that combines different scientific methods to identify and create antibodies efficiently. Clients, including pharmaceutical companies and research institutions, partner with AbCellera to enhance their drug development processes. Unlike many competitors, AbCellera focuses on challenging targets that traditional methods struggle to address. The company aims to accelerate the development of new medicines through collaborations, generating revenue from discovery services, licensing agreements, and its own therapeutic programs.

Company Stage

Grant

Total Funding

$620.9M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

5%

1 year growth

0%

2 year growth

31%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic collaborations with firms like Viking Global Investors and Biogen expand AbCellera's capabilities and market opportunities.
  • AbCellera's participation in high-profile industry conferences and presentations, such as AACR, showcases its cutting-edge research and strengthens its industry reputation.
  • The company's internal pipeline of therapeutic programs offers potential for significant breakthroughs and new treatments.

What critics are saying

  • The highly competitive and rapidly evolving biopharmaceutical market requires continuous innovation to maintain a competitive edge.
  • The recent resignation of board member Peter Thiel could lead to strategic and governance challenges.

What makes AbCellera Biologics unique

  • AbCellera's proprietary technology platform accelerates antibody discovery, making it faster and more efficient than traditional methods.
  • The company's ability to tackle challenging targets that have been difficult to address with traditional methods sets it apart in the biopharmaceutical market.
  • AbCellera's collaborative business model, which includes partnerships with leading investment firms and biotech companies, enhances its innovation and market reach.

Help us improve and share your feedback! Did you find this helpful?